Literature DB >> 27149641

Synthesis, Evaluation, and Mechanism Study of Novel Indole-Chalcone Derivatives Exerting Effective Antitumor Activity Through Microtubule Destabilization in Vitro and in Vivo.

Jun Yan1, Jie Chen1, Shun Zhang1, Jinhui Hu1, Ling Huang1, Xingshu Li1.   

Abstract

Twenty-nine novel indole-chalcone derivatives were synthesized and evaluated for antiproliferative activity. Among them, 14k exhibited most potent activity, with IC50 values of 3-9 nM against six cancer cells, which displayed a 3.8-8.7-fold increase in activity when compare with compound 2. Further investigation revealed 14k was a novel tubulin polymerization inhibitor binding to the colchicine site. Its low cytotoxicity toward normal human cells and nearly equally potent activity against drug-resistant cells revealed the possibility for cancer therapy. Cellular mechanism studies elucidated 14k arrests cell cycle at G2/M phase and induces apoptosis along with the decrease of mitochondrial membrane potential. Furthermore, good metabolic stability of 14k was observed in mouse liver microsomes. Importantly, 14k and its phosphate salt 14k-P inhibited tumor growth in xenograft models in vivo without apparent toxicity, which was better than the reference compound CA-4P and 2. In summary, 14k deserves consideration for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27149641     DOI: 10.1021/acs.jmedchem.6b00021

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  22 in total

1.  An orally antitumor chalcone hybrid inhibited HepG2 cells growth and migration as the tubulin binding agent.

Authors:  Wang Yan; Chen Xiangyu; Li Ya; Wang Yu; Xu Feng
Journal:  Invest New Drugs       Date:  2019-02-11       Impact factor: 3.850

2.  6-MOMIPP, a novel brain-penetrant anti-mitotic indolyl-chalcone, inhibits glioblastoma growth and viability.

Authors:  Shengnan Du; Jeffrey G Sarver; Christopher J Trabbic; Paul W Erhardt; Allen Schroering; William A Maltese
Journal:  Cancer Chemother Pharmacol       Date:  2018-11-13       Impact factor: 3.333

3.  Novel synthetic chalcones induce apoptosis in the A549 non-small cell lung cancer cells harboring a KRAS mutation.

Authors:  Yiqiang Wang; Andreas Hedblom; Steffi K Koerner; Mailin Li; Finith E Jernigan; Barbara Wegiel; Lijun Sun
Journal:  Bioorg Med Chem Lett       Date:  2016-10-24       Impact factor: 2.823

4.  Therapeutic Applications of Self-assembled Indole-3-butanoyl-polyethylenimine Nanostructures.

Authors:  Reena Singh; Diksha Jha; Uma Dhawan; Hemant K Gautam; Pradeep Kumar
Journal:  Indian J Microbiol       Date:  2022-04-18

5.  Design, Synthesis, In Vitro Biological Activity Evaluation and Stabilized Nanostructured Lipid Carrier Formulation of Newly Synthesized Schiff Bases-Based TMP Moieties.

Authors:  Syed Nasir Abbas Bukhari; Mohamed Y Zakaria; Muhammad Usman Munir; Naveed Ahmad; Mervat A Elsherif; Rasha Emad Badr; Ahmad Khalaf Hassan; Ali H Abu Almaaty; Islam Zaki
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-28

6.  Dual targeting of MDM2 with a novel small-molecule inhibitor overcomes TRAIL resistance in cancer.

Authors:  Anup Kumar Singh; Shikha S Chauhan; Sudhir Kumar Singh; Ved Vrat Verma; Akhilesh Singh; Rakesh Kumar Arya; Shrankhla Maheshwari; Md Sohail Akhtar; Jayanta Sarkar; Vivek M Rangnekar; Prem M S Chauhan; Dipak Datta
Journal:  Carcinogenesis       Date:  2016-11-01       Impact factor: 4.944

7.  Benzothiazole Pyrazoline: Acid-Switchable Absorption and Fluorescence of Photoinduced Electron Transfer (PET).

Authors:  Maadh Jumaah; Melati Khairuddean; Sohaib Jumaah Owaid
Journal:  J Fluoresc       Date:  2022-02-04       Impact factor: 2.217

8.  Synthesis and biological evaluation of alpha-bromoacryloylamido indolyl pyridinyl propenones as potent apoptotic inducers in human leukaemia cells.

Authors:  Romeo Romagnoli; Filippo Prencipe; Luisa Carlota Lopez-Cara; Paola Oliva; Stefania Baraldi; Pier Giovanni Baraldi; Francisco Estévez-Sarmiento; José Quintana; Francisco Estévez
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

9.  Design, Synthesis and Anti-Tumor Activity of Novel Benzimidazole-Chalcone Hybrids as Non-Intercalative Topoisomerase II Catalytic Inhibitors.

Authors:  Wei Zhou; Wenjin Zhang; Yi Peng; Zhi-Hong Jiang; Lanyue Zhang; Zhiyun Du
Journal:  Molecules       Date:  2020-07-12       Impact factor: 4.411

10.  Structure-Activity Relationship Studies of β-Lactam-azide Analogues as Orally Active Antitumor Agents Targeting the Tubulin Colchicine Site.

Authors:  Dong-Jun Fu; Ling Fu; Ying-Chao Liu; Jun-Wei Wang; Yu-Qing Wang; Bing-Kai Han; Xiao-Rui Li; Chuang Zhang; Feng Li; Jian Song; Bing Zhao; Ruo-Wang Mao; Ruo-Han Zhao; Sai-Yang Zhang; Li Zhang; Yan-Bing Zhang; Hong-Min Liu
Journal:  Sci Rep       Date:  2017-10-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.